238
views
0
recommends
+1 Recommend
0 collections
    20
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Human Tissues Contain CD141 hi Cross-Presenting Dendritic Cells with Functional Homology to Mouse CD103 + Nonlymphoid Dendritic Cells

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8 + T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141 hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c + and CD14 + tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141 hi DCs were closely related to blood CD141 + DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting.

          Abstract

          Graphical Abstract

          Highlights

          ► Human tissues contain CD1c + DCs, CD14 + DCs, and a CD141 hi cross-presenting DC subset ► CD141 hi DCs migrate to draining lymph nodes and probably arise from blood CD141 + DCs ► Human tissue CD141 hi DCs are homologous to mouse CD103 + or CD8 + DCs ► Human tissue CD1c + DCs are homologous to mouse CD4 + DCs

          Related collections

          Most cited references46

          • Record: found
          • Abstract: found
          • Article: not found

          Differential antigen processing by dendritic cell subsets in vivo.

          Dendritic cells (DCs) process and present self and foreign antigens to induce tolerance or immunity. In vitro models suggest that induction of immunity is controlled by regulating the presentation of antigen, but little is known about how DCs control antigen presentation in vivo. To examine antigen processing and presentation in vivo, we specifically targeted antigens to two major subsets of DCs by using chimeric monoclonal antibodies. Unlike CD8+ DCs that express the cell surface protein CD205, CD8- DCs, which are positive for the 33D1 antigen, are specialized for presentation on major histocompatibility complex (MHC) class II. This difference in antigen processing is intrinsic to the DC subsets and is associated with increased expression of proteins involved in MHC processing.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs.

            CD8+ cytotoxic T lymphocytes (CTLs) mediate resistance to infectious agents and tumours. Classically, CTLs recognize antigens that are localized in the cytoplasm of target cells, processed and presented as peptide complexes with class I molecules of the major histocompatibility complex (MHC). However, there is evidence for an exogenous pathway whereby antigens that are not expected to gain access to the cytoplasm are presented on MHC class I molecules. The most dramatic example is the in vivo phenomenon of cross-priming: antigens from donor cells are acquired by bone-marrow-derived host antigen-presenting cells (APCs) and presented on MHC class I molecules. Two unanswered questions concern the identity of this bone-marrow-derived cell and how such antigens are acquired. Here we show that human dendritic cells, but not macrophages, efficiently present antigen derived from apoptotic cells, stimulating class I-restricted CD8+ CTLs. Our findings suggest a mechanism by which potent APCs acquire antigens from tumours, transplants, infected cells, or even self-tissue, for stimulation or tolerization of CTLs.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells

              In recent years, human dendritic cells (DCs) could be subdivided into CD304+ plasmacytoid DCs (pDCs) and conventional DCs (cDCs), the latter encompassing the CD1c+, CD16+, and CD141+ DC subsets. To date, the low frequency of these DCs in human blood has essentially prevented functional studies defining their specific contribution to antigen presentation. We have established a protocol for an effective isolation of pDC and cDC subsets to high purity. Using this approach, we show that CD141+ DCs are the only cells in human blood that express the chemokine receptor XCR1 and respond to the specific ligand XCL1 by Ca2+ mobilization and potent chemotaxis. More importantly, we demonstrate that CD141+ DCs excel in cross-presentation of soluble or cell-associated antigen to CD8+ T cells when directly compared with CD1c+ DCs, CD16+ DCs, and pDCs from the same donors. Both in their functional XCR1 expression and their effective processing and presentation of exogenous antigen in the context of major histocompatibility complex class I, human CD141+ DCs correspond to mouse CD8+ DCs, a subset known for superior antigen cross-presentation in vivo. These data define CD141+ DCs as professional antigen cross-presenting DCs in the human.
                Bookmark

                Author and article information

                Journal
                Immunity
                Immunity
                Immunity
                Cell Press
                1074-7613
                1097-4180
                27 July 2012
                27 July 2012
                : 37
                : 1
                : 60-73
                Affiliations
                [1 ]Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne NE2 4HH, UK
                [2 ]Singapore Immunology Network, Agency for Science, Technology and Research (A STAR), 138648, Singapore
                [3 ]Singapore General Hospital, 169608, Singapore
                [4 ]University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK
                [5 ]National University Hospital, 119074, Singapore
                [6 ]Yong Loo Lin School of Medicine, National University of Singapore, 119077, Singapore
                [7 ]KK Women's and Children's Hospital, 229989, Singapore
                [8 ]Duke-NUS Graduate Medical School, 169857, Singapore
                [9 ]Singapore Institute of Clinical Sciences, Agency for Science, Technology and Research (A STAR), 117609, Singapore
                Author notes
                []Corresponding author matthew.collin@ 123456newcastle.ac.uk
                [∗∗ ]Corresponding author florent_ginhoux@ 123456immunol.a-star.edu.sg
                [10]

                These authors contributed equally to this work

                [11]

                These authors contributed equally to this work

                Article
                IMMUNI2389
                10.1016/j.immuni.2012.04.012
                3476529
                22795876
                447f745d-1c6b-4806-b442-657e772c74ef
                © 2012 ELL & Excerpta Medica.

                This document may be redistributed and reused, subject to certain conditions.

                History
                : 19 December 2011
                : 21 March 2012
                : 7 April 2012
                Categories
                Article

                Immunology
                Immunology

                Comments

                Comment on this article